Oprettelsen af effektive mekanismer til overvågning af både human - og veterinærmedicinske lægemidler er EMEA' s hovedprioritet i 2002.
The establishment of effective pharmacovigilance mechanisms for the supervision of medicines for both human and veterinary use is a major priority for the EMEA in 2002.